Advertisement
Singapore markets close in 14 minutes

  • Straits Times Index

    3,276.38
    -11.37 (-0.35%)
     

  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     

  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     

  • FTSE 100

    8,108.44
    +29.58 (+0.37%)
     

  • Bitcoin USD

    64,418.32
    +591.66 (+0.93%)
     

  • CMC Crypto 200

    1,389.17
    -7.37 (-0.53%)
     

  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     

  • Dow

    38,085.80
    -375.12 (-0.98%)
     

  • Nasdaq

    15,611.76
    -100.99 (-0.64%)
     

  • Gold

    2,359.70
    +17.20 (+0.73%)
     

  • Crude Oil

    83.75
    +0.18 (+0.22%)
     

  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     

  • FTSE Bursa Malaysia

    1,573.92
    +4.67 (+0.30%)
     

  • Jakarta Composite Index

    7,062.79
    -92.50 (-1.29%)
     

  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Tesla, Meta Platforms, and Valneva rise premarket

Investing.com
·1-min read

By Peter Nurse

Investing.com -- Stocks in focus in premarket trade on Friday, December 23rd. Please refresh for updates.

Tesla (NASDAQ:TSLA) stock rose 1.3% after CEO Elon Musk said he will not sell any more of the electric car manufacturer’s stock for around two years, removing some of the overhang which has contributed to its deep selloff.

Meta Platforms (NASDAQ:META) stock rose 0.4% after the Facebook owner agreed to pay $725 million to resolve a class-action lawsuit accusing the social media giant of allowing third parties, including Cambridge Analytica, to access users' personal information.

ADVERTISEMENT

Activision Blizzard (NASDAQ:ATVI) stock rose 0.2% after Microsoft (NASDAQ:MSFT), up 0.2%, defended its $69B bid to buy the "Call of Duty" maker, saying it would benefit gamers and gaming companies alike.

General Motors (NYSE:GM) stock rose 0.5% despite the auto giant having to recall 140,000 Chevrolet Bolt EVs in North America because of fire risks. Valneva (NASDAQ:VALN) ADRs rose 3.3% after the vaccines company said it had completed a regulatory submission step with the FDA for its single-shot chikungunya, a mosquito-borne viral disease, vaccine candidate.

Related Articles

Tesla, Meta Platforms, and Valneva rise premarket

Loop Capital unsure what Warren Buffett sees in Paramount, cuts stock to Sell

Wall St set to slip at open as investors assess inflation data